BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8019465)

  • 1. Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation.
    Maruta A; Kanamori H; Fukawa H; Harano H; Matsuzaki M; Miyashita H; Fujisawa S; Noguchi T; Ogawa K; Sakai R
    Bone Marrow Transplant; 1994 Apr; 13(4):417-22. PubMed ID: 8019465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation.
    Maruta A; Tanabe J; Hashimoto C; Kato K; Kanamori H; Fukawa H; Miyashita H; Fujisawa S; Fujita H; Matsuzaki M; Motomura S; Kodama F; Ookawa S; Mohri H; Ishigatsubo Y
    Bone Marrow Transplant; 1999 Aug; 24(4):359-63. PubMed ID: 10467323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and natural history of hepatitis C infections in liver transplant recipients.
    Weinstein JS; Poterucha JJ; Zein N; Wiesner RH; Persing DH; Rakela J
    J Hepatol; 1995; 22(1 Suppl):154-9. PubMed ID: 7602070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation.
    Locasciulli A; Bacigalupo A; VanLint MT; Cavalletto D; Pontisso P; Testa M; Masera G; Shulman HM; Portmann B; Alberti A
    Bone Marrow Transplant; 1995 Sep; 16(3):407-11. PubMed ID: 8535314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M; Sharma A; Das A; Chawla Y
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
    Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
    Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT; Young KC; Yang YJ; Lei HY; Wu HL
    Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction.
    Prieto M; Olaso V; Verdú C; Córdoba J; Gisbert C; Rayón M; Carrasco D; Berenguer M; Higón MD; Berenguer J
    Hepatology; 1995 Aug; 22(2):413-7. PubMed ID: 7635408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S; Franke A; Lee JH; Herrmann G; Ruster B; Roth WK
    Hepatology; 1996 Nov; 24(5):1003-9. PubMed ID: 8903367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
    Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
    Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure.
    Villamil FG; Hu KQ; Yu CH; Lee CH; Rojter SE; Podesta LG; Makowka L; Geller SA; Vierling JM
    Hepatology; 1995 Nov; 22(5):1379-86. PubMed ID: 7590651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
    Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.